http://iii/investment/detail?code=cotn:VAL.L&display=news http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7796088&from=rss RNS Number : 6916I ValiRx PLC 17 March 2010 ValiRx Plc ("ValiRx") ValiRx announces SELFCheck kit range sales and distribution agreement for North America ValiRx is pleased to announce that ValiMedix, its sales and marketing division, has concluded a sales and distribution license agreement... Wed, 17 Mar 2010 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7792103&from=rss RNS Number : 5750I ValiRx PLC 15 March 2010 ValiRx Plc ("ValiRx") ValiRx announces good stability data for VAL201 ValiRx is pleased to announce that initial stability testing of its novel anti-androgen VAL201 has been completed, with the molecule showing good stability in simulated gastric... Mon, 15 Mar 2010 11:07:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7782730&from=rss LONDON, March 9 (Reuters) - ValiRx Plc: * Funding and commercial partnership deal with the Laboratory of Government Chemistry and Horizon Discovery * Provides funding for the development of ValiRx'S Hypergenomics technology into new gene activity based diagnostics and screening products *... Tue, 09 Mar 2010 07:26:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7782503&from=rss RNS Number : 2570I ValiRx PLC 09 March 2010 ValiRx Plc ("ValiRx" or the "Company") ValiRx announces funding and partnership agreement ValiRx is pleased to announce that is has entered into a funding and commercial partnership agreement with the Laboratory of Government Chemistry and Horizon... Tue, 09 Mar 2010 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7779396&from=rss RNS Number : 1767I ValiRx PLC 05 March 2010 ValiRx plc (the "Company") Issue of equity The Company announces that it has issued 3,600,000 new ordinary shares in the Company ("Ordinary Shares") at 1p per share in lieu of fees owed. The admission of 3,600,000 new Ordinary Shares to trading... Fri, 05 Mar 2010 15:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7767786&from=rss RNS Number : 7845H ValiRx PLC 26 February 2010 ValiRx plc (the "Company") Total Voting Rights For the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of par value 1p each in the capital... Fri, 26 Feb 2010 16:30:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7751680&from=rss RNS Number : 2022H ValiRx PLC 16 February 2010 ValiRx plc (the "Company") Issue of equity The Company announces that it has issued, in aggregate, 900,000 new ordinary shares in the Company ("Ordinary Shares") at 1p per share in lieu of fees owed. The admission of 900,000 new Ordinary Shares... Tue, 16 Feb 2010 09:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7729152&from=rss RNS Number : 3402G ValiRx PLC 29 January 2010 ValiRx plc (the "Company") Total Voting Rights For the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, the total number of shares in issue as at the date of this notice... Fri, 29 Jan 2010 10:10:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7711052&from=rss RNS Number : 7433F ValiRx PLC 19 January 2010 ValiRx plc ("ValiRx" or the "Company") ValiRx announces successful outcome to the first phase of the Eurostar GeneICE programme together with a new strategic product delivery system. ValiRx is pleased to announce that it has successfully completed... Tue, 19 Jan 2010 07:01:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7711030&from=rss RNS Number : 7433F ValiRx PLC 19 January 2010 ValiRx plc ("ValiRx" or the "Company") ValiRx announces successful outcome to the first phase of the Eurostar GeneICE programme together with a new strategic product delivery system. ValiRx is pleased to announce that it has successfully completed... Tue, 19 Jan 2010 07:01:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7703241&from=rss RNS Number : 4636F ValiRx PLC 13 January 2010 ValiRx plc (the "Company") Issue of equity The Company is pleased to announce that it issued 200,000 new ordinary shares in the Company ("Ordinary Shares") at 1.13p per share, to Dutchess Opportunities Fund, II, LP. The admission of 200,000 new... Wed, 13 Jan 2010 07:56:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7689124&from=rss RNS Number : 8742E ValiRx PLC 31 December 2009 ValiRx plc (The "Company") Issue of Equity The Company is pleased to announce that on 29 December 2009, it issued and allotted 100,000 new ordinary shares of 1p each in the Company ("Ordinary Shares") at 1p per share, to Dutchess Opportunities... Thu, 31 Dec 2009 08:03:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7688257&from=rss RNS Number : 8398E ValiRx PLC 30 December 2009 ValiRx plc (the "Company") Result of General Meeting The Company announces that all resolutions put to shareholders at today's general meeting have been duly approved. Enquiries: ValiRx Plc www.valirx.com Tel: +44 (0) 20 3008... Wed, 30 Dec 2009 13:57:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:VAL.L&display=news&action=article&articleid=7681640&from=rss RNS Number : 5596E ValiRx PLC 22 December 2009 ValiRx PLC (AIM: VAL) ("ValiRx" or the "Company") Regional Funding Company secures further development funding to progress key diagnostics development to clinical validation ValiRx Plc (AIM: VAL) is pleased to announce that it has secured a... Tue, 22 Dec 2009 12:19:00 GMT